Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis.
about
Immunotherapy for tuberculosis: future prospectsPotential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosisLeishmania Infection Engages Non-Receptor Protein Kinases Differentially to Persist in Infected HostsMultifunctional Abl kinases in health and diseaseTuberculosis drug discovery in the post-post-genomic eraTherapeutic targeting of autophagy in neurodegenerative and infectious diseasesCan host receptors for fungi be targeted for treatment of fungal infections?Low doses of imatinib induce myelopoiesis and enhance host anti-microbial immunityAdjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate VaccinationImmune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious DiseasesNaloxonazine, an Amastigote-Specific Compound, Affects Leishmania Parasites through Modulation of Host-Encoded FunctionsEnhancing hit identification in Mycobacterium tuberculosis drug discovery using validated dual-event Bayesian modelsIdentification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growthThe Abl and Arg kinases mediate distinct modes of phagocytosis and are required for maximal Leishmania infectionNovel high throughput pooled shRNA screening identifies NQO1 as a potential drug target for host directed therapy for tuberculosisNew tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeuticsIndispensable functions of ABL and PDGF receptor kinases in epithelial adherence of attaching/effacing pathogens under physiological conditions.Host-directed antimicrobial drugs with broad-spectrum efficacy against intracellular bacterial pathogens.Advancing host-directed therapy for tuberculosis.Targeting Batf2 for infectious diseases and cancer.Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a reviewMonocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis.Abelson tyrosine kinase controls phagosomal acidification required for killing of Mycobacterium tuberculosis in human macrophagesTargeting Drug-Sensitive and -Resistant Strains of Mycobacterium tuberculosis by Inhibition of Src Family Kinases Lowers Disease Burden and PathologyFresh approaches to anti-infective therapies.A Fluorescent Probe for Detecting Mycobacterium tuberculosis and Identifying Genes Critical for Cell Entry.Elimination of intracellularly residing Mycobacterium tuberculosis through targeting of host and bacterial signaling mechanisms.Host-directed therapeutics for tuberculosis: can we harness the host?Systems kinomics for characterizing host responses to high-consequence pathogens at the NIH/NIAID Integrated Research Facility-Frederick.Inflammation and tuberculosis: host-directed therapies.New insights into the interaction of Mycobacterium tuberculosis and human macrophages.The immune response and antibacterial therapy.Host-Directed Therapies for Tuberculosis.Peptide Arrays for Kinome Analysis of Livestock Species.Pharmacological Targeting of the Host-Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs.Tuberculous and non-tuberculous granulomatous lymphadenitis in patients receiving imatinib mesylate (glivec) for metastatic gastrointestinal stromal tumor.Back to the future: host-targeted chemotherapeutics for drug-resistant TB.Genetics-directed drug discovery for combating Mycobacterium tuberculosis infection.The Src kinases Hck, Fgr and Lyn activate Arg to facilitate IgG-mediated phagocytosis and Leishmania infection.Imatinib Triggers Phagolysosome Acidification and Antimicrobial Activity against Mycobacterium bovis Bacille Calmette-Guérin in Glucocorticoid-Treated Human Macrophages.
P2860
Q26741261-50F6B0A6-551F-4D2D-91F9-6F2D37BCC964Q26746099-FF77F4D9-08E1-4975-B2C6-EDFBD2BA23EFQ26752531-BFD43EFF-119A-4F76-8227-E505A3F601B0Q26771277-871B7BEE-B777-492A-8A44-839776298984Q26864729-B282DF38-D8B3-480F-8AA2-C3125E00A870Q27021382-3BCF6324-EEB9-46E4-9106-ABB774E49BAAQ27026653-3C3C6006-A110-43A7-9248-C08275552217Q27320733-FE24F4EC-7993-4B5E-9A7F-CFA9C54B924EQ28074536-1D37CE4F-DB62-462A-A7D6-106742C73D6AQ28081001-F47BB4A1-6E41-4E9B-A3FC-690765A8B39BQ28468455-143F9079-267A-4F42-A5DA-A73789F7A46CQ28487748-30255436-FF82-4DBB-880B-15A65D10BE1BQ28539975-0897DB58-7537-4B3B-A79F-490A7B764753Q28594369-3FC7CD30-6C76-4804-8134-857F0FB35EB6Q28830471-BFE95381-71C1-48F1-9A68-B8BF6003FC20Q30371980-96F3446B-C554-40E3-A3D3-63BB629E850CQ33913024-C2AC2C37-44C6-489C-83AD-C6915C395726Q34026297-6A9F5819-2303-4EA4-9E1B-EAC0605D6F98Q34466861-067FD69D-6AC4-47E1-BFF9-1E9D26018785Q36413539-DA62BAD1-C77B-4AA6-89C3-96B4BB623258Q36653997-1E354715-90BC-4EFE-BFD2-0240E28FF594Q36694988-CED19389-AE99-4DAF-8920-0D4A7F1C0B76Q36934732-EB578ABA-9581-4BA0-8D54-3BFD464157D3Q36973195-02CB993F-CEE8-4FC8-B312-2E759C8E69DEQ37015858-681327D8-0F12-410F-8D66-44708168B98EQ37516443-80AB21F1-FE41-4BD9-BE3E-C44AC080E456Q38056148-1B8F529F-0111-4F1C-97C5-D7791CC49FC8Q38168037-0B25DFFD-7960-4D80-89C9-BDB114DF52E6Q38192567-73692488-AF90-4824-9B54-F07E6C5030B5Q38203352-0FF3F778-990E-4448-878D-D81AF8F6B488Q38206868-22DC6118-7E4D-4F31-B28A-91D39CFC67DDQ38246131-F8045239-FDF9-46FB-979E-05B49D4A0973Q38489473-EC8D0192-7933-4BD5-BDD9-80CC3FA101F1Q38668711-F37A520C-7F89-46B2-99E9-BE0C358B941DQ39173330-93E9DC9D-2B0E-4FB5-965B-DBA10E2F4B76Q39636564-62DC8E43-FD69-4A71-9DF5-B59A83315C96Q39637771-44B445D9-2FF5-41E6-956A-C5F7ADFEA854Q39980133-41A74C06-4C11-4A3A-B142-A415FC227997Q40630924-9E7A1408-8276-44FC-9ACD-2CCE7177276CQ40656316-BE7362F2-6E6D-49B9-83A0-CF5847632227
P2860
Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Imatinib-sensitive tyrosine ki ...... targets against tuberculosis.
@en
Imatinib-sensitive tyrosine ki ...... targets against tuberculosis.
@nl
type
label
Imatinib-sensitive tyrosine ki ...... targets against tuberculosis.
@en
Imatinib-sensitive tyrosine ki ...... targets against tuberculosis.
@nl
prefLabel
Imatinib-sensitive tyrosine ki ...... targets against tuberculosis.
@en
Imatinib-sensitive tyrosine ki ...... targets against tuberculosis.
@nl
P2093
P2860
P1433
P1476
Imatinib-sensitive tyrosine ki ...... targets against tuberculosis.
@en
P2093
Daniel Kalman
Kimberly R Powell
M Analise Zaunbrecher
Mani Cheruvu
Padmini Salgame
Ruth J Napier
Thomas M Shinnick
Wasiulla Rafi
William Bornmann
P2860
P304
P356
10.1016/J.CHOM.2011.09.010
P577
2011-11-01T00:00:00Z